Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.

Studies have demonstrated that common polymorphisms in Th1 and Th2 cytokine genes can alter gene expression, modulate the balance between Th1/Th2 responsiveness, and influence susceptibility for autoimmune disorders, infectious diseases, and cancer. We analyzed one or more single nucleotide polymorphisms (SNPs) in 20 candidate Th1/Th2 genes in a population-based case-control study of non-Hodgkin lymphoma (NHL; n = 518 cases, 597 controls) among women in Connecticut. SNPs in critical genes, IL4, IL5, IL6, and IL10, were associated with risk for NHL and in some instances with a specific histologic subtype. Analysis of 4 SNPs in the IL10 promoter (-3575T>A, -1082A>G, -819C>T, and -592C>A) revealed that both the AGCC haplotype (odds ratio [OR] = 1.54, 95% confidence interval [CI] = 1.21-1.96, P < .001) and the TATA haplotype (OR = 1.37, 95% CI = 1.05-1.79, P = .02) were associated with increased risk for B-cell lymphomas. In contrast, the IL4-1098G allele was associated with increased risk of T-cell lymphomas (OR = 3.84; 95% CI = 1.79-8.22; P < .001). Further, the IL10 and IL4 SNP associations remained significant after adjusting for multiple comparisons. These results suggest that SNPs in Th2 cytokine genes may be associated with risk of NHL.

[1]  Theodore R Holford,et al.  Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. , 2006, The Lancet. Oncology.

[2]  V. Anttila,et al.  Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. , 2003, The Journal of infectious diseases.

[3]  Sparholt,et al.  The polymorphisms S503P and Q576R in the interleukin‐4 receptor α gene are associated with atopy and influence the signal transduction , 1999, Immunology.

[4]  G. Marti,et al.  Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma , 2004, Leukemia.

[5]  S. Chanock,et al.  Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia , 2005, Leukemia.

[6]  R. Schwartz,et al.  The role of CD28 in the activation of T lymphocytes to proliferate in response to IL4. , 1995, Research in immunology.

[7]  P. Boyle,et al.  Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women , 2003, British Journal of Cancer.

[8]  Brian Staats,et al.  SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes , 2004, Nucleic Acids Res..

[9]  D. Solomon,et al.  Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. , 1995, American journal of ophthalmology.

[10]  M. Caligiuri,et al.  A review of the association between interleukin-10 and human B-cell malignancies , 1998, Cancer Immunology, Immunotherapy.

[11]  J. Blay,et al.  Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. , 1993, Blood.

[12]  Theodore R Holford,et al.  Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut. , 2004, American journal of epidemiology.

[13]  S. Swain,et al.  IL4 dictates T-cell differentiation. , 1993, Research in immunology.

[14]  A. Fietta,et al.  The frequency of interleukin-10- and interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted lung. , 2005, Transplantation proceedings.

[15]  D. Harlan,et al.  ASSOCIATION OF CYTOKINE POLYMORPHIC INHERITANCE AND IN VITRO CYTOKINE PRODUCTION IN ANTI-CD3/CD28-STIMULATED PERIPHERAL BLOOD LYMPHOCYTES1 , 2001, Transplantation.

[16]  L. Keen.  The extent and analysis of cytokine and cytokine receptor gene polymorphism. , 2002, Transplant immunology.

[17]  B. Müller-Myhsok,et al.  Promoter haplotypes of the interleukin-10 gene influence proliferation of peripheral blood cells in response to helminth antigen , 2004, Genes and Immunity.

[18]  H. Spits,et al.  Production of IL4 by human T cells and regulation of differentiation of T-cell subsets by IL4. , 1993, Research in immunology.

[19]  R. Flavell,et al.  Interchromosomal associations between alternatively expressed loci , 2005, Nature.

[20]  R. Westendorp,et al.  Interleukin 10 secretion in relation to human IL-10 locus haplotypes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  U. Spengler,et al.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production , 1991, The Journal of experimental medicine.

[22]  C. Paige,et al.  Interleukins 1, 4 and 6 induce the colony formation of human bone marrow B lineage cells , 1991, European journal of immunology.

[23]  Stephen Chanock,et al.  Candidate Genes and Single Nucleotide Polymorphisms (SNPs) in the Study of Human Disease , 2002, Disease markers.

[24]  Peter Lipsky,et al.  Cytokines and their role in lymphoid development, differentiation and homeostasis , 2002, Current opinion in allergy and clinical immunology.

[25]  S. Heath,et al.  Genomic analysis of Th1–Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression , 2003, Genes and Immunity.

[26]  W. Ip,et al.  Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus , 2004, Genes and Immunity.

[27]  R. Westendorp,et al.  Novel Single Nucleotide Polymorphisms in the Distal IL-10 Promoter Affect IL-10 Production and Enhance the Risk of Systemic Lupus Erythematosus1 , 2001, The Journal of Immunology.

[28]  M. Clerici,et al.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases , 1996, Clinical microbiology reviews.

[29]  G. Binetti,et al.  Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease , 2004, Neuroscience Letters.

[30]  K. Deichmann,et al.  A novel polymorphism in the 5′ promoter region of the human interleukin-4 receptor α-chain gene is associated with decreased soluble interleukin-4 receptor protein levels , 2001, Immunogenetics.

[31]  P. Dřevínek,et al.  Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. , 2004, The Journal of rheumatology.

[32]  N. Laird,et al.  IL10 gene polymorphisms are associated with asthma phenotypes in children , 2004, Genetic epidemiology.

[33]  D. Schaid,et al.  Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.

[34]  L. Excoffier,et al.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.

[35]  M. Harada,et al.  Association between IL-4 genotype and IL-4 production in the Japanese population , 2002, Genes and Immunity.

[36]  F. Davies,et al.  THE USE OF BIOLOGICAL VARIABLES TO PREDICT OUTCOME IN MULTIPLE MYELOMA , 1997, British journal of haematology.

[37]  Matthew W. Hahn,et al.  Positive Selection on a Human-Specific Transcription Factor Binding Site Regulating IL4 Expression , 2003, Current Biology.

[38]  N. Rothman,et al.  Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. , 2004, American journal of epidemiology.

[39]  D. Kunz,et al.  Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. , 2003, Critical care medicine.

[40]  Ming-Tseh Lin,et al.  Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. , 2003, The New England journal of medicine.

[41]  F. Martín-Saavedra,et al.  Autocrine IL-4 Gene Regulation at Late Phases of TCR Activation in Differentiated Th2 Cells1 , 2002, The Journal of Immunology.

[42]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[43]  C. Wanidworanun,et al.  Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. , 1993, Journal of immunology.

[44]  T. Kimman,et al.  Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. , 2003, The Journal of infectious diseases.

[45]  J. Antonen,et al.  Th2 cytokine genotypes are associated with a milder form of primary Sjögren’s syndrome , 2005, Annals of the rheumatic diseases.

[46]  G. Salles,et al.  Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. , 2004, Blood.

[47]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[48]  F. Pociot,et al.  Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females. , 2003, Human molecular genetics.

[49]  Y. Ikeda,et al.  T-helper (Th)1/Th2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma , 2001, Cancer Immunology, Immunotherapy.

[50]  Stephen J Chanock,et al.  Mining variations in genes of innate and phagocytic immunity: current status and future prospects , 2000, Current opinion in hematology.

[51]  L. Gergely,et al.  Intracellular IL‐4/IFN‐gamma producing peripheral T lymphocyte subsets in B cell non‐Hodgkin's lymphoma patients , 2004, European journal of haematology.

[52]  Tom R. Gaunt,et al.  Polymorphisms in the interleukin‐4 and interleukin‐4 receptor α chain genes confer susceptibility to asthma and atopy in a Caucasian population , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[53]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Weisenburger,et al.  An update of the epidemiology of non-Hodgkin's lymphoma. , 2003, Clinical lymphoma.

[55]  K. Ardlie,et al.  Alleles carried at positions −819 and −592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae , 2003, Immunogenetics.

[56]  S. Weiland,et al.  A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. , 2003, The Journal of allergy and clinical immunology.

[57]  M. Lazarus,et al.  An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[58]  S. Chanock,et al.  A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. , 2002, The Journal of infectious diseases.